Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
about
RetinoblastomaConservative treatment modalities in retinoblastomaCarboplatin-associated ototoxicity in children with retinoblastoma.Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicityOcular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular RetinoblastomaOutcomes of cataract surgery following radiation treatment for retinoblastoma.Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with up- regulation of hERG1 channels and of the VEGF-A pathway.Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review.Retinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location, and ageDiagnosis and management of retinoblastoma.Focal laser treatment in addition to chemotherapy for retinoblastoma.Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors.Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.Overview: chemotherapy for retinoblastoma: an expanding area of clinical research.Chebulagic acid from Terminalia chebula causes G1 arrest, inhibits NFκB and induces apoptosis in retinoblastoma cells.Multidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastomaEffects of celecoxib in human retinoblastoma cell lines and in a transgenic murine model of retinoblastoma.Systemic carboplatin for retinoblastoma: change in tumour size over time.Folic acid transport via high affinity carrier-mediated system in human retinoblastoma cells.Predictive factors of invasion in eyes with retinoblastoma enucleated after eye salvage treatments.Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy.A clinical update and radiologic review of pediatric orbital and ocular tumors.Historical trends in the use of radiation therapy for pediatric cancers: 1973-2008.Retinoblastoma major review with updates on Middle East management protocols.Efficacy of vincristine and carboplatin as chemo-reduction for advanced bilateral retinoblastoma, the Saudi experience.Molecular Insights on Post-chemotherapy Retinoblastoma by Microarray Gene Expression AnalysisComparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.Molecular pathology of retinoblastoma.Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization.Ophthalmic artery chemosurgery for the management of retinoblastoma in eyes with extensive (>50%) retinal detachment.Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage.Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group.Revisiting old drugs as novel agents for retinoblastoma: in vitro and in vivo antitumor activity of cardenolides.Rabbit model of retinoblastoma.Clinical outcome and regression patterns of retinoblastoma treated with systemic chemoreduction and focal therapy: A prospective study.microRNA-497 overexpression decreases proliferation, migration and invasion of human retinoblastoma cells via targeting vascular endothelial growth factor A.Editorial: chemotherapy for retinoblastoma.Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.Etoposide Upregulates Survival Favoring Sphingosine-1-Phosphate in Etoposide-Resistant Retinoblastoma Cells.
P2860
Q21558539-F3E31AFE-C259-4AD4-8C17-447C1E310A53Q27024214-4453BDBE-FCEB-4846-B529-2B4B54B3E1E3Q30513911-E1E1E2F6-5641-4EAB-AFB2-11D276CE4952Q33400825-5906BD94-7F03-4835-8EB4-A15606EBCBE4Q33437979-55438266-95C7-4C0E-A0EA-BE2C1830BFB7Q33511395-6A97847E-B48A-41CF-9769-46E61C5B2174Q33699387-1BEFA1B1-32EC-4409-B20B-1BC4D3E64245Q34123428-DBB33972-25EC-41E2-BC62-8791A3378E2DQ34251018-D1395EB7-FF03-4F30-ABE5-FB20EF2D57AAQ34500975-3775CB39-2425-4AE2-9A92-66B3AAB1EEE6Q34551012-7A6B301C-C141-41A1-B43F-74AD425CF125Q34557627-017CB58F-7916-4192-B0ED-2406134BF09FQ34589401-2E449A7E-918E-4F63-8FBB-1731A04815C2Q34603733-E4D8EEE0-E13D-4CA1-83B8-15BC0600A493Q34621002-17D2F563-FC5B-44EE-9C01-BF6EBB2D3484Q35234561-83D2E803-A214-414A-8058-03099D1C280DQ35592655-0D99F87D-17EA-4390-BD1A-FEAC2176C226Q35593681-8661FD9D-1BBA-4866-850A-7DA3A4B9FC16Q35593982-0F8D1197-8393-4706-977C-9C779BF3AC69Q35892580-D0C53041-1B89-431F-BA04-9BD01E5BEB26Q36276642-240A587D-25A4-4C6C-80CA-03BA7C4C3A68Q36615019-1521FCB6-ED26-4208-8829-F356BF3A233AQ36723098-C546C7EC-6CD7-4D44-A888-BD241CD2A5DCQ36795804-20F62625-40FF-473E-9E15-99EF966D2523Q37060594-28F75EB5-52CA-45A8-B364-6200020478FDQ37163480-0AFF3842-A69D-4B65-8964-6266CA56CB03Q37203063-55A053F5-4F1A-4C76-B992-003A6935F11FQ37490145-43171340-82D3-4134-A75D-1CA7177B45A1Q37789156-87F5DDC9-5DAF-4290-83B0-95F498630F70Q37996374-071E6C87-A3DE-4A6C-AAF4-6018CE7E6395Q38001657-370F28E2-CC5B-4FE0-AD7F-1504D99AE20FQ38045274-5C17BCB5-3A7C-4006-939A-8FA1D2A16266Q39055366-1C153FB1-5789-4659-AFA6-EC67BF991C69Q39618628-EDE6ADB8-B149-4951-AE95-5CC4071DA5AFQ39967459-184E3C15-48A1-4CE1-AD14-ECF7DB688F1BQ41109252-F527F2E5-929B-4B8A-A768-425FBBB37D1BQ41899216-3F95543F-2199-4C5F-BE8E-3DBAF5481E55Q43976750-5B44B001-1D7F-4385-ACD9-0DD0EB2E6AE1Q43976760-0AA1FA88-FD90-412B-9D8E-585360113545Q47588678-7D00CC10-51B2-49C1-99D4-46CA06AFC97F
P2860
Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
@ast
Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
@en
type
label
Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
@ast
Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
@en
prefLabel
Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
@ast
Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
@en
P2093
P356
P1476
Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
@en
P2093
A T Meadows
B Himelstein
C L Shields
D L Friedman
J A Shields
P356
10.1200/JCO.2000.18.1.12
P407
P577
2000-01-01T00:00:00Z